Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
3.880 CHF
70.43 M CHF
72.20 M CHF
8.51 M
About FORMYCON AG
Sector
CEO
Stefan Glombitza
Headquarters
Munich
Website
Founded
2007
ISIN
DE000A1EWVY8
FIGI
BBG00LVDGVQ6
Formycon AG engages in the manufacture of biosimilar drugs and formulations. Its product candidates include FYB201, FYB202, FYB203, and FYB205, which focuses in the opthalmology and immunology disease areas. The company was founded by Friedrich Wilhelm Steinweg and Nicolas Combé in 2007 and is headquartered in Munich, Germany.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of FYB is 48.563 CHF — it has decreased by −1.39% in the past 24 hours. Watch FORMYCON AG stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BX exchange FORMYCON AG stocks are traded under the ticker FYB.
We've gathered analysts' opinions on FORMYCON AG future price: according to them, FYB price has a max estimate of 95.71 CHF and a min estimate of 59.12 CHF. Watch FYB chart and read a more detailed FORMYCON AG stock forecast: see what analysts think of FORMYCON AG and suggest that you do with its stocks.
FYB stock is 1.41% volatile and has beta coefficient of 1.22. Track FORMYCON AG stock price on the chart and check out the list of the most volatile stocks — is FORMYCON AG there?
Today FORMYCON AG has the market capitalization of 875.08 M, it has increased by 7.44% over the last week.
Yes, you can track FORMYCON AG financials in yearly and quarterly reports right on TradingView.
FORMYCON AG is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
FYB net income for the last half-year is −9.72 M CHF, while the previous report showed 68.76 M CHF of net income which accounts for −114.14% change. Track more FORMYCON AG financial stats to get the full picture.
No, FYB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 30, 2024, the company has 238.00 employees. See our rating of the largest employees — is FORMYCON AG on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. FORMYCON AG EBITDA is −21.70 M CHF, and current EBITDA margin is 1.88%. See more stats in FORMYCON AG financial statements.
Like other stocks, FYB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade FORMYCON AG stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So FORMYCON AG technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating FORMYCON AG stock shows the sell signal. See more of FORMYCON AG technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.